GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » Cash, Cash Equivalents, Marketable Securities

Synthetic MR AB (XSAT:SYNT) Cash, Cash Equivalents, Marketable Securities : kr16.74 Mil (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB Cash, Cash Equivalents, Marketable Securities?

Synthetic MR AB's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 (kr27.79 Mil) to Dec. 2023 (kr21.32 Mil) but then stayed the same from Dec. 2023 (kr21.32 Mil) to Mar. 2024 (kr16.74 Mil).

Synthetic MR AB's annual cash, cash equivalents, marketable securities increased from Dec. 2021 (kr11.55 Mil) to Dec. 2022 (kr40.50 Mil) but then declined from Dec. 2022 (kr40.50 Mil) to Dec. 2023 (kr21.32 Mil).


Synthetic MR AB Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Synthetic MR AB's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB Cash, Cash Equivalents, Marketable Securities Chart

Synthetic MR AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.75 13.00 11.55 40.50 21.32

Synthetic MR AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.61 28.31 27.79 21.32 16.74

Synthetic MR AB Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Synthetic MR AB  (XSAT:SYNT) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Synthetic MR AB Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Gurus Find Hot Information Technology Stocks

By James Li James Li 06-10-2016

Syntel to Present at Investor Conference

By Marketwired Marketwired 05-08-2018

Syntel Joins Google Cloud Partner Program

By Marketwired Marketwired 03-26-2018

A Solid Pick at a Fair Price

By Jae Jun Jae Jun 03-31-2015

Insiders Are Investing in Syntel

By Kyle Ferguson Kyle Ferguson 04-27-2017

Interim CEO Invests in IT Company

By Jennifer Chiou Jennifer Chiou 12-07-2016